Pneumococcal 13-Valent Conjugate Vaccine(Zhejiang Vacin Bio-Pharmaceutical)

13价肺炎球菌多糖结合疫苗（艾美卫信）

Report date: 2026/01/22 11:04:41

Base Information

Drug NamePneumococcal 13-Valent Conjugate Vaccine(Zhejiang Vacin Bio-Pharmaceutical)

Drug Alias NameN/A

ClassificationVaccines > Application > Prophylactic vaccineVaccines > Biological material > Bacterial vaccineVaccines > Vaccine type > Multivalent vaccine +[4]

Mechanisms of ActionImmunostimulants

TargetsNot applicable

Therapy Area/IndicationsMeningitisSepsisPneumonia, Pneumococcal +[6]

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryMainland China

CombinationsNo

Global Highest StatusPhase 3 Clinical

Highest Status in ChinaPhase 3 Clinical

Originator CompaniesAimei Weixin BioPharm (Zhejiang) Co Ltd

China Registration ClassN/A

Develop Information

Active CompaniesAimei Weixin BioPharm (Zhejiang) Co Ltd

Inactive CompaniesN/A

Active IndicationsMeningitisSepsisPneumococcal Infections +[5]

Inactive IndicationsPneumonia, Pneumococcal

Other Information

ATC CodeN/A